Multicenter randomized controlled clinical study of Longteng Tongluo Recipe in the treatment of lung cancer pai
- Conditions
- ung Cancer Pain
- Registration Number
- ITMCTR2200006504
- Lead Sponsor
- onghua hospital, Shanghai University of Traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
1) Patients with cancer pain who are diagnosed with lung cancer by neurocytology, pathology and clinical and have a clear pain location.
2) Radiotherapy and chemotherapy (including radionuclide therapy) have been stopped for more than 1 month.
3) Those who can use external drugs and have no history of drug or food allergy.
4) Age =18 years old and =85 years old, good compliance.
5) Expected survival > 12 weeks.
6) The subjects have no major organ dysfunction and normal blood routine, liver, kidney and heart function.
7) Be able to understand the situation of this study and sign the informed consent.
1) Those without a clear pathological diagnosis.
2) Patients undergoing radiotherapy and chemotherapy or less than 3 to 4 weeks after radiotherapy and chemotherapy.
3) The expected survival period is less than 3 months.
4) Combined with serious diseases such as heart, liver, kidney and hematopoietic system.
5) Pregnant or lactating patients detected by HCG.
6) Those with a history of uncontrollable mental illness.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method RS pain score;
- Secondary Outcome Measures
Name Time Method Equivalent Morphine Consumption;Security indicators;